Published May 19, 2023 | Version v1

Supplemental data for: A bibliometric assessment of the incidence of amyloid-Eszett (Aß), a false positive of amyloid-beta (Aβ), in the neurodegenerative disease literature

  • 1. Borys Grinchenko Kyiv University
  • 2. Independent researcher

Description

One claimed reason for the development of Alzheimer’s disease (AD), a prominent neurodegenerative disease, is the extracellular aggregation of amyloid-beta (Aβ). A linguistic or formatting error has resulted in the misrepresentation of the Greek letter β with the German letter Eszett (ß), resulting in the formation of a non-existent compound, amyloid-Eszett (Aß). These datasets offer a quantified appreciation of the AD-related literature, carrying a mention of this false positive in the title, abstract and keywords of papers indexed in the Web of Science Core Collection and Scopus. Also, as a curiosity given the popularity of this large language model, we asked the questions to ChatGPT. This AI chatbot developed by OpenAI was able to recognize Eszett as a linguistic or typographic error, within this context, recognizing Aß and Aβ as equals. This erroneous substitution of a Greek letter (in Aβ) by a German one (Aß), despite giving a non-existent compound, will likely not change the underlying scientific conclusions of the affected papers, although errata might be useful to enlighten others, including metadata managers and journal copyeditors, so as not to repeat the same mistake.

Files

Suppl. text ChatGPT and β-carotene vs ß-carotene.pdf

Files (460.5 kB)

Name Size Download all
md5:c0da27ea307c605f8d7e9a45f3b8eed3
83.3 kB Download
md5:b1a2ce0bd630ba6b0967b90a9010fd3e
112.1 kB Download
md5:943035701be345c72dcc9cd9016e20f4
60.0 kB Preview Download
md5:c01d7ff6e2507d50ea3d983e40b7b11f
205.1 kB Preview Download

Additional details

References

  • Nazarovets, S., & Teixeira da Silva, J. A. (2023). A bibliometric assessment of the incidence of amyloid‐ Eszett (Aß), a false positive of amyloid‐ beta (Aβ), in the neurodegenerative disease literature. European Journal of Neuroscience, 115(April), 1–3. https://doi.org/10.1111/ejn.16058